Skip to contents
NHLBI Women's Health Initiative
Women's Health Initiative banner
 

WHI HOME

CONTACT

BROAD AGENCY ANNOUNCEMENT

WHI PARTICIPANT WEBSITE

WHI SCIENTIFIC RESOURCES WEBSITE

PRESS RELEASES

PUBLICATIONS

LEGACY CONFERENCE

WHI PARTICIPANT UPDATES

NHLBI POSTMENOPAUSAL HORMONE THERAPY

Estrogen-Alone Study

Estrogen-Plus-Progestin Study

DIETARY MODIFICATION TRIAL

CALCIUM and VITAMIN D TRIAL

OBSERVATIONAL STUDY

Q & As for WHI STUDY PARTICIPANTS

WHI Background and Overview

Why WHI?

WHI Community Prevention Study

Additional Resources

   

WHI Update

CT/OS ENROLLMENT STATUS

Recruitment for the Women's Health Initiative (WHI) began in September 1993. The last participant in the CT enrolled in December 1998. The CaD trial enrolled women who were already in the HT and/or DM trials for up to 2 years and their randomizations continued until July 31, 2000. The OS completed enrollment on December 31, 1998.

recruitment numbers: H R T 27,347; D M  48,835; C a D 36,282;  Observational Study  93,676

Recruitment Issues

Each clinical center faced its individual challenge in recruiting participants especially for the HT component. In some areas of the country, hormones are routinely prescribed to alleviate menopausal symptoms and thus finding eligible women to participate in the HT was a challenging endeavor. In other areas, women are confused about the risks of taking hormones due to reports of a potential increase in breast cancer risk. The WHI was the first clinical trial to address and answer the benefits and the potential adverse effects of HT.


Fact Sheets

NHLBI Press Releases

 
 
Department of Health and Human Services National Institutes of Health National Heart, Lung, and Blood Institute

Please send us your feedback, comments, and questions
by using the appropriate link on the page, Contact the NHLBI.

Note to users of screen readers and other assistive technologies: please report your problems here.

Link to DHHS Link to NIH Link to NHLBI Link to DHHS Link to WHI Home